BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 23379956)

  • 1. Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli.
    Hofsteenge N; van Nimwegen E; Silander OK
    BMC Microbiol; 2013 Feb; 13():25. PubMed ID: 23379956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells.
    Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas syringae pv.
    Patel RR; Kandel PP; Traverso E; Hockett KL; Triplett LR
    mBio; 2021 Apr; 12(2):. PubMed ID: 33849974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persister Escherichia coli Cells Have a Lower Intracellular pH than Susceptible Cells but Maintain Their pH in Response to Antibiotic Treatment.
    Goode O; Smith A; Zarkan A; Cama J; Invergo BM; Belgami D; Caño-Muñiz S; Metz J; O'Neill P; Jeffries A; Norville IH; David J; Summers D; Pagliara S
    mBio; 2021 Aug; 12(4):e0090921. PubMed ID: 34281389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medium chain unsaturated fatty acid ethyl esters inhibit persister formation of Escherichia coli via antitoxin HipB.
    Wang M; Fang K; Hong SMC; Kim I; Jang IS; Hong SH
    Appl Microbiol Biotechnol; 2018 Oct; 102(19):8511-8524. PubMed ID: 30088019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells.
    Goormaghtigh F; Fraikin N; Putrinš M; Hallaert T; Hauryliuk V; Garcia-Pino A; Sjödin A; Kasvandik S; Udekwu K; Tenson T; Kaldalu N; Van Melderen L
    mBio; 2018 Jun; 9(3):. PubMed ID: 29895634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Integration Host Factor in Escherichia coli Persister Formation.
    Nicolau SE; Lewis K
    mBio; 2022 Feb; 13(1):e0342021. PubMed ID: 34982597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putrescine controls the formation of Escherichia coli persister cells tolerant to aminoglycoside netilmicin.
    Tkachenko AG; Kashevarova NM; Karavaeva EA; Shumkov MS
    FEMS Microbiol Lett; 2014 Dec; 361(1):25-33. PubMed ID: 25283595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial persister cell formation and dormancy.
    Wood TK; Knabel SJ; Kwan BW
    Appl Environ Microbiol; 2013 Dec; 79(23):7116-21. PubMed ID: 24038684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Dynamic Transition of Persistence toward the Viable but Nonculturable State during Stationary Phase Is Driven by Protein Aggregation.
    Dewachter L; Bollen C; Wilmaerts D; Louwagie E; Herpels P; Matthay P; Khodaparast L; Khodaparast L; Rousseau F; Schymkowitz J; Michiels J
    mBio; 2021 Aug; 12(4):e0070321. PubMed ID: 34340538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous persister cells formation in Acinetobacter baumannii.
    Barth VC; Rodrigues BÁ; Bonatto GD; Gallo SW; Pagnussatti VE; Ferreira CA; de Oliveira SD
    PLoS One; 2013; 8(12):e84361. PubMed ID: 24391945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dormancy is not necessary or sufficient for bacterial persistence.
    Orman MA; Brynildsen MP
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3230-9. PubMed ID: 23629720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens.
    Goneau LW; Yeoh NS; MacDonald KW; Cadieux PA; Burton JP; Razvi H; Reid G
    Antimicrob Agents Chemother; 2014; 58(4):2089-97. PubMed ID: 24449771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deacylated tRNA Accumulation Is a Trigger for Bacterial Antibiotic Persistence Independent of the Stringent Response.
    Wood WN; Mohler K; Rinehart J; Ibba M
    mBio; 2021 Jun; 12(3):e0113221. PubMed ID: 34126764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific Enrichment and Proteomics Analysis of Escherichia coli Persisters from Rifampin Pretreatment.
    Sulaiman JE; Hao C; Lam H
    J Proteome Res; 2018 Nov; 17(11):3984-3996. PubMed ID: 30336045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-Dependent Persister Formation in Escherichia coli.
    Shan Y; Brown Gandt A; Rowe SE; Deisinger JP; Conlon BP; Lewis K
    mBio; 2017 Feb; 8(1):. PubMed ID: 28174313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Historical Perspective on Bacterial Persistence.
    Verstraeten N; Knapen W; Fauvart M; Michiels J
    Methods Mol Biol; 2016; 1333():3-13. PubMed ID: 26468095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persister Heterogeneity Arising from a Single Metabolic Stress.
    Amato SM; Brynildsen MP
    Curr Biol; 2015 Aug; 25(16):2090-8. PubMed ID: 26255847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow-cytometry analysis reveals persister resuscitation characteristics.
    Mohiuddin SG; Kavousi P; Orman MA
    BMC Microbiol; 2020 Jul; 20(1):202. PubMed ID: 32640993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single cell observations show persister cells wake based on ribosome content.
    Kim JS; Yamasaki R; Song S; Zhang W; Wood TK
    Environ Microbiol; 2018 Jun; 20(6):2085-2098. PubMed ID: 29528544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.